OncoMed Pharmaceuticals Inc. | Key People and Executives
Perry A. Karsen
Executive Chairman
John A. Lewicki
President, Chief Executive Officer & Director
Jack W. Lasersohn
Independent Director
Rick E. Winningham
Independent Director
Deepa R. Pakianathan
Independent Director
Denise Vera Pollard-Knight
Independent Director
Michael S. Wyzga
Independent Director
Jonathan D. Root
Independent Director
Perry A. Karsen
Executive Chairman
John A. Lewicki
President, Chief Executive Officer & Director
Yvonne Li
Chief Financial & Accounting Officer
Austin Gurney
Chief Scientific Officer & SVP-Cellular Biology
Leonardo Faoro
Vice President-Clinical Development
Ann Kapoun
Senior VP-Translational Medicine
Robert J. Stagg
Senior VP-Clinical Research and Development
Sylvia R. Wheeler
Investor Relations Contact
Jill Henrich
Senior VP-Regulatory Affairs & Quality Assurance
Alicia J. Hager
Vice President & General Counsel
Jack W. Lasersohn
Independent Director
Rick E. Winningham
Independent Director
Deepa R. Pakianathan
Independent Director
Denise Vera Pollard-Knight
Independent Director
Michael S. Wyzga
Independent Director
Jonathan D. Root
Independent Director
| Address |
800 Chesapeake Drive
Redwood City California 94063
United States
|
|
Employees
|
- |
| Website |
http://www.oncomed.com |
| Updated |
09/14/2018 |
| OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. |
